Published in Respir Res on November 23, 2010
Etiology of sarcoidosis: does infection play a role? Yale J Biol Med (2012) 1.08
Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol (2012) 1.04
Overview of neurosarcoidosis: recent advances. J Neurol (2014) 1.02
Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis. J Immunol (2013) 0.95
Occupational causes of sarcoidosis. Curr Opin Allergy Clin Immunol (2012) 0.91
Sarcoidosis: Immunopathogenesis and Immunological Markers. Int J Chronic Dis (2013) 0.85
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med (2014) 0.85
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol. Ann Am Thorac Soc (2015) 0.83
Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4(+) T Cell Proliferation. Am J Respir Cell Mol Biol (2017) 0.83
Concomitant axillary mycobacteriosis and neuro-sarcoidosis: diagnostic pitfalls. BMJ Case Rep (2011) 0.82
Molecular Analysis of Sarcoidosis Granulomas Reveals Antimicrobial Targets. Am J Respir Cell Mol Biol (2016) 0.76
Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis. PLoS One (2016) 0.75
Mycobacterium and sarcoidosis: Old wine in a new bottle. Lung India (2014) 0.75
High throughput 16SrRNA gene sequencing reveals the correlation between Propionibacterium acnes and sarcoidosis. Respir Res (2017) 0.75
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol (2001) 3.79
Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science (2009) 3.71
Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med (2006) 3.12
Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med (2005) 2.69
SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol Microbiol (2003) 2.62
Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J (1961) 2.46
Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun (1995) 2.39
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine (1997) 1.83
Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun (2006) 1.76
Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis (2002) 1.59
T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol (2008) 1.52
Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J Clin Microbiol (2006) 1.49
The T cell response to secreted antigens of Mycobacterium tuberculosis. Immunobiology (1994) 1.44
Heterogeneity of the repertoire of T cells of tuberculosis patients and healthy contacts to Mycobacterium tuberculosis antigens separated by high-resolution techniques. Infect Immun (1992) 1.34
Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun (2009) 1.19
Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol (2007) 1.16
Screening of predicted secreted antigens from Mycobacterium bovis reveals the immunodominance of the ESAT-6 protein family. Infect Immun (2010) 1.15
Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses. Respir Res (2008) 1.14
Rapid diagnosis of smear-negative tuberculosis using immunology and microbiology with induced sputum in HIV-infected and uninfected individuals. PLoS One (2007) 1.10
How flow cytometry is changing the study of TB immunology and clinical diagnosis. Cytometry A (2008) 1.08
Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis. J Clin Immunol (2007) 1.08
Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax (2002) 1.02
Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol (2003) 0.96
Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology (2007) 0.93
Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex? Am J Respir Cell Mol Biol (2002) 0.92
Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis. BMC Infect Dis (2009) 0.87
Applied clinical immunology in sarcoidosis. Curr Opin Pulm Med (2002) 0.86
T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1992) 0.81
Distribution of Mycobacterium ulcerans in buruli ulcer endemic and non-endemic aquatic sites in Ghana. PLoS Negl Trop Dis (2008) 2.16
Therapeutic Whole-Lung Lavage for Pulmonary Alveolar Proteinosis: A Procedural Update. J Bronchology Interv Pulmonol (2015) 2.04
A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med (2010) 1.98
Case series: Tension pneumothorax complicating narrow-bore enteral feeding tube placement. J Intensive Care Med (2010) 1.50
PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol (2003) 1.44
Syndrome of iron pill aspiration. Chest (2002) 1.39
Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol (2003) 1.37
Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med (2009) 1.30
Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. J Virol (2004) 1.21
Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun (2009) 1.19
Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med (2011) 1.17
Spinal cord neurosarcoidosis. Am J Med Sci (2014) 1.17
Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol (2003) 1.13
Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activity. J Immunol (2003) 1.11
UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV. Vaccine (2012) 1.10
Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factor. J Immunol (2008) 1.08
Idiopathic pulmonary fibrosis or not: antibiotic prophylaxis for all patients on immunosuppressants. Thorax (2013) 1.07
Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV. Vaccine (2009) 1.05
Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest (2006) 1.05
Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol (2012) 1.04
Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus. Viral Immunol (2005) 1.02
Gle1 functions during mRNA export in an oligomeric complex that is altered in human disease. Cell (2013) 1.00
Low numeracy is associated with increased odds of 30-day emergency department or hospital recidivism for patients with acute heart failure. Circ Heart Fail (2012) 0.99
Murine hepatitis virus nonstructural protein 4 regulates virus-induced membrane modifications and replication complex function. J Virol (2010) 0.98
TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J Clin Invest (2014) 0.98
Murine cytomegalovirus with a transposon insertional mutation at open reading frame m155 is deficient in growth and virulence in mice. J Virol (2004) 0.97
Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis. J Immunol (2013) 0.95
HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail. Front Biosci (2008) 0.95
Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-γ expression. J Clin Immunol (2012) 0.91
Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma). Sarcoidosis Vasc Diffuse Lung Dis (2006) 0.89
Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis. Respir Med (2008) 0.88
Transudative chylothorax: report of two cases and review of the literature. Lung (2005) 0.87
Auto-positive end-expiratory pressure: mechanisms and treatment. Cleve Clin J Med (2005) 0.87
The prostacyclin analogue treprostinil blocks NFkappaB nuclear translocation in human alveolar macrophages. J Biol Chem (2002) 0.87
Treatment of sarcoidosis. Semin Respir Crit Care Med (2010) 0.85
Murine cytomegalovirus with a transposon insertional mutation at open reading frame M35 is defective in growth in vivo. J Virol (2003) 0.85
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med (2014) 0.85
A young patient with a minimal smoking history presents with bullous emphysema and recurrent pneumothorax. Chest (2007) 0.84
Single-chain urokinase in empyema induced by Pasturella multocida. Exp Lung Res (2009) 0.84
A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis. Respir Med (2013) 0.84
Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide. Am J Respir Cell Mol Biol (2010) 0.83
Obstructive fibrinous tracheal pseudomembrane. Ann Thorac Surg (2011) 0.82
Modeling haplotype-haplotype interactions in case-control genetic association studies. Front Genet (2012) 0.82
Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression. Clin Immunol (2005) 0.82
No difference in survivorship after unicompartmental knee arthroplasty with or without an intact anterior cruciate ligament. Knee Surg Sports Traumatol Arthrosc (2012) 0.81
In vitro and in vivo characterization of a murine cytomegalovirus with a mutation at open reading frame m166. J Virol (2003) 0.81
HIV vaccine rationale, design and testing. Curr HIV Res (2005) 0.81
Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF. J Autoimmun (2005) 0.81
Muscle power and function two years after unicompartmental knee replacement. Knee (2011) 0.80
Testosterone influences renal electrolyte excretion in SHR/y and WKY males. BMC Physiol (2008) 0.80
Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis. Autoimmunity (2003) 0.80
Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment. J Acquir Immune Defic Syndr (2016) 0.80
Epstein-Barr virus vaccine development: a lytic and latent protein cocktail. Front Biosci (2008) 0.79
Surfactant blocks lipopolysaccharide signaling by inhibiting both mitogen-activated protein and IkappaB kinases in human alveolar macrophages. Am J Respir Cell Mol Biol (2003) 0.79
HIV vaccines: brief review and discussion of future directions. Expert Rev Vaccines (2005) 0.79
A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances. ACS Chem Neurosci (2015) 0.78
Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary? AIDS Res Ther (2005) 0.78
A Multi-Vector, Multi-Envelope HIV-1 Vaccine. J Pediatr Pharmacol Ther (2007) 0.78
CD8+ T-cells: are they sufficient to prevent, contain or eradicate HIV-1 infection? Curr Drug Targets Infect Disord (2005) 0.78
Determination of femoral component size in unicompartmental knee replacement. Knee (2008) 0.78
SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development? Curr HIV Res (2009) 0.78
Alveolar macrophage cathelicidin deficiency in severe sarcoidosis. J Innate Immun (2012) 0.78
Hypertension prevalence awareness, treatment and control in North Nashville. Tenn Med (2006) 0.77
Genetic analyses of gene function and pathogenesis of murine cytomegalovirus by transposon-mediated mutagenesis. J Clin Virol (2002) 0.77
Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis. Chest (2013) 0.77
Pulmonary hypertension caused by sarcoidosis. Clin Chest Med (2008) 0.76
Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study. J Crit Care (2010) 0.76
What is sarcoidosis? Respir Med (2013) 0.75
Reply to: A Rapid Infuser System for Whole-Lung Lavage. J Bronchology Interv Pulmonol (2016) 0.75
Sarcoidosis--no business of the bronchoscopist. J Thorac Cardiovasc Surg (2012) 0.75
Right-sided heart catheterization: de rigueur in sarcoidosis? Chest (2010) 0.75
Infectious antigens may play a role in the pathogenesis of sarcoidosis. Medscape J Med (2008) 0.75
Clinical application of beryllium lymphocyte proliferation testing. Clin Diagn Lab Immunol (2003) 0.75
Reprocessing the bronchoscope: the challenges. Semin Respir Crit Care Med (2004) 0.75
Sarcoidosis. Semin Respir Crit Care Med (2010) 0.75
Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: a phase 1 study. Sarcoidosis Vasc Diffuse Lung Dis (2015) 0.75
Detectability of vasopressin in continuous venovenous hemodialysis effluent of patients with vasodilatory shock treated with exogenous arginine vasopressin. Pharmacotherapy (2011) 0.75
Hypothermia is associated with poor outcome in pediatric trauma patients. Am J Emerg Med (2010) 0.75
EBUS-TBNA for the diagnosis of sarcoidosis: is it the only game in town? J Bronchology Interv Pulmonol (2013) 0.75
Venous Thromboembolism After Adult Lung Transplantation: A Frequent Event Associated with Lower Survival. Transplantation (2017) 0.75
Trifurcation: an unusual variant of the left main stem bronchus. J Bronchology Interv Pulmonol (2014) 0.75
Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis. Sarcoidosis Vasc Diffuse Lung Dis (2015) 0.75
A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP). Autoimmunity (2009) 0.75